Evaluation of some psychological factors in psoriatic patients.

  • Pedram Noormohammadpour Mail Tehran University of Medical Sciences, Department of Dermatology, Razi Hospital, Tehran, Iran
  • Yousef Fakour Department of Psychiatry, Tehran University of Medical Sciences, Razi hospital, Tehran, Iran
  • Mohammad Javad Nazemei Tehran University of Medical Sciences, Department of Dermatology, Razi Hospital, Tehran, Iran
  • Amirhooshang Ehsani Tehran University of Medical Sciences, Department of Dermatology, Razi Hospital, Tehran, Iran
  • Fatemeh Gholamali Tehran University of Medical Sciences, Department of Dermatology, Razi Hospital, Tehran, Iran
  • Afsaneh Morteza Farzan research center, free researcher. Tehran, Iran
  • Leila Mokhtari Master of Clinical Psychology, Ministry of Education
  • Najmeh Khosrovanmehr Shahid Beheshti University of medical sciences, Imam Hussein Hospital. Tehran, Iran
Mental Health, PASI score, Psoriasis, Psychology


Background: Psoriasis is a disease which may have a direct impact on the psychological and social aspects of the patient, particularly due to its visibility. To date, we are unaware of any study showing a relationship between psoriasis and psychological parameters such as psychological vulnerability and coping strategies . Objective: The aim of this study was to evaluate the effects of psoriasis on some psychological parameters in an Iranian population.
Methods: Patients having histopathologically confirmed psoriasis for at least 6 months attending the Dermatology Clinic of Razi Hospital were included if they agreed to participate in the study. Patients with history of schizophrenia, major depression or other psychological disorders were excluded. All patients were at least 18 years old. The patients were then referred to the researchers for filling out the appropriate questionnaires under the guidance of an involved psychologist. To evaluate skin involvement, Psoriasis Area Severity Index (PASI) score was ca culated and used for all patients. All data were stored in files for further analysis.
Results: There were 101 females and 99 males with the mean age of 43.2(±16.32). The mean PASI Score was 6.58 ± 6.04. Diffuse skin involvement was the commonest form of disease (133 patients, 66.5%). The highest score for Illness perception belonged to those with genitalia involvement (185.2, worst illness perception), and the lowest score for Illness perception belonged to those with nail involvement (168.2). Consistently, the lowest score of facing the problems (CISS: approach strategy to disease) belonged to those with hand involvement (50.5) whereas the highest score belonged to those with genitalia involvement (60.4). There was a significant correlation between psychological vulnerability vs. Illness perception score as well as psychological vulnerability vs. coping strategies score. Surprisingly, PASI score had an insignificant relationship with illness perception, coping strategies or psychological vulnerability scor.
Conclusion: PASI score as a representing factor of skin involvement has a limited role in predicting the effect of psoriasis on mental status and illness perception of psoriatic patients. Psychological vulnerability of the patients is the main predicting factor of illness perception and coping strategies (representing patients approach to their disease or their treatment beliefs).


Sarilar M, Koic E, Dervinja F.Personal experiences of the psoriasis and its relation to the stressful life events. Coll Antropol 2011; 35 Suppl 2: 241-243.

Kumar S, Kachhawha D, Das Koolwal G, Gehlot S, Awasthi A.Psychiatric morbidity in psoriasis patients: a pilot study. Indian J Dermatol Venereol Leprol 2011; 77: 625.

Reich A, Hrehorow E, Szepietowski JC.Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol 2010; 90: 257-263.

Han C, Lofland JH, Zhao N, Schenkel B.Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis. J Drugs Dermatol 2011; 10: 843-850.

Picardi A, Lega I, Tarolla E.Suicide risk in skin disorders. Clin Dermatol 2013; 31: 47-56.

Kimball AB, Wu EQ, Guerin A, Yu AP, Tsaneva M, Gupta SR, Bao Y, Mulani PM.Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol 2012; 67: 651-657 .

Dominguez PL, Han J, Li T, Ascherio A, et al.Depression and the risk of psoriasis in US women. J Eur Acad Dermatol Venereol 2012.(Article first published online: 3 OCT 2012

Derogatis LR, Lipman RS, Covi L. SCL-90: An outpatient psychiatric rating scale, preliminary report. Psychopharmacol. Bull 1973; 9: 13–28.

Endler NS,Parker, JD. Multidimensional Assessment of Coping: A Critical Evaluation. Journal of Personality and Social Psychology 1990; 58: 844-854.

Moss-morris R, Weinman J, Petrie K, et al. The revised illness perception questionnaire (IPQ-R). Psychology and Health 2002; 17: 1–16.

Leibovici V, Canetti L, Yahalomi S, Cooper-Kazaz R, Bonne O, Ingber A, Bachar E.Well being, psychopathology and coping strategies in psoriasis compared with atopic dermatitis: a controlled study. J Eur Acad Dermatol Venereol 2010; 24: 897-903.

Zhang J, Li L, Lu Q, Xiao R, Wen H, Yan K, Li Y, Zhou Y, Su Y, Zhang G, Li W, Zhou J.Acute stress enhances contact dermatitis by promoting nuclear factor-kappaB DNA-binding activity and interleukin-18 expression in mice. J Dermatol 2010; 37: 512-521.

Saad AA, Ashcroft DM, Watson KD, Symmons DP, Noyce PR, Hyrich KL.Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies. Arthritis Care Res (Hoboken) 2010; 62: 345-353.

Leung YY, Ho KW, Zhu TY, Tam LS, Kun EW, Li EK.Testing scaling assumptions, reliability and validity of medical outcomes study short-form 36 health survey in psoriatic arthritis. Rheumatology (Oxford) 2010; 49: 1495-1501.

Kimball AB, Bensimon AG, Guerin A, Yu AP, Wu EQ, Okun MM, Bao Y, Gupta SR, Mulani PM.Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial. Am J Clin Dermatol 2011; 12: 51-62.

Bohm D, Stock Gissendanner S, Bangemann K, Snitjer I, Werfel T, Weyergraf A, Schulz W, Jager B, Schmid-Ott G.Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. J Eur Acad Dermatol Venereol 2013; 27: 220-226.

1Husted JA, Tom BD, Farewell VT, Gladman DD.Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritis. Arthritis Care Res (Hoboken) 2012; 64: 758-765.

Grozdev I, Kast D, Cao L, Carlson D, Pujari P, Schmotzer B, Babineau D, Kern E, McCormick T, Cooper KD, Korman NJ.Physical and mental impact of psoriasis severity as measured by the compact Short Form-12 Health Survey (SF-12) quality of life tool. J Invest Dermatol 2012; 132: 1111-1116.

Varni JW, Globe DR, Gandra SR, Harrison DJ, Hooper M, Baumgartner S.Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases. Eur J Pediatr 2012; 171: 485-92.

Tang MM, Chang CC, Chan LC, Heng A.Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study. Int J Dermatol 2013; 52: 314-322.

Shankar V, Ghosh S, Ghosh K, Chaudhuri U.Pasi and pqol-12 score in psoriasis: is there any correlation? Indian J Dermatol 2011; 56: 287-289.

Remröd C, Sjöström K, Svensson A. Psychological differences between early- and late-onset psoriasis: a study of personality traits, anxiety and depression in psoriasis. Br J Dermatol. 2013; 169: 344-350.

How to Cite
Noormohammadpour P, Fakour Y, Nazemei MJ, Ehsani A, Gholamali F, Morteza A, Mokhtari L, Khosrovanmehr N. Evaluation of some psychological factors in psoriatic patients. Iran J Psychiatry. 10(1):37-42.